RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
RESMED INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026
$239.77+0.80 (+0.33%)
Close on Oct 19, 2026
- Market cap
- $34.79B
- P/E (TTM)
- 23.0
- Dividend yield
- 1.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100M
Shares held, 13F filers
Institutional holders
885
93 new, 137 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 30 sales
Net sold $21.13M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| AustralianSuper Pty Ltd | 8,276,381 | 5.70% | 13G (passive) | Jun 30, 2026 |
| Vanguard Portfolio Management | 7,886,489 | 5.41% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 12,783,715 | 8.70% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 11,961,706 | 8.21% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of RMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12,317,194 | – | $2.40B | +223,171 | 0.04% |
| Vanguard Capital Management LLC | 9,474,129 | – | $1.85B | +7,713 | 0.04% |
| Vanguard Portfolio Management LLC | 7,913,661 | – | $1.54B | +49,739 | 0.07% |
| State Street Corp | 6,680,735 | – | $1.30B | +37,567 | 0.04% |
| Geode Capital Management, LLC | 4,352,320 | – | $845.16M | −553 | 0.05% |
| Bank of New York Mellon Corp | 4,197,610 | – | $818.03M | −727,776 | 0.13% |
| First Trust Advisors LP | 2,278,696 | – | $444.07M | +740,871 | 0.26% |
| Invesco Ltd. | 2,063,578 | – | $402.15M | +106,964 | 0.03% |
| Morgan Stanley | 1,928,931 | – | $375.91M | −757,890 | 0.02% |
| Northern Trust Corp | 1,696,674 | – | $330.65M | −29,019 | 0.04% |
| Nordea Investment Management Ab | 1,388,008 | – | $269.57M | +354,627 | 0.22% |
| Deutsche Bank AG\ | 1,322,313 | – | $257.69M | −100,552 | 0.07% |
| UBS Group AG | 1,289,300 | – | $251.26M | +562,489 | 0.03% |
| Swedbank AB | 1,274,897 | – | $248.45M | −75,337 | 0.21% |
| Charles Schwab Investment Management Inc | 1,222,473 | – | $238.24M | +87,174 | 0.03% |
| Goldman Sachs Group Inc | 1,160,426 | – | $226.14M | +156,221 | 0.02% |
| Arrowstreet Capital, Limited Partnership | 1,129,739 | – | $220.16M | +679,489 | 0.10% |
| Dimensional Fund Advisors LP | 1,123,577 | – | $219.00M | +119,359 | 0.04% |
| Legal & General Group Plc | 942,614 | – | $183.70M | −47,747 | 0.04% |
| Aqr Capital Management LLC | 910,623 | – | $177.14M | +560,783 | 0.06% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 885 | 100M | 93 / 312 | 358 / 137 | 11M | 8M |
| Q1 2026 | 943 | 98M | 105 / 362 | 322 / 99 | 25M | 6M |
| Q4 2025 | 948 | 97M | 114 / 333 | 340 / 100 | 11M | 5M |
| Q3 2025 | 950 | 93M | 119 / 345 | 325 / 75 | 6M | 7M |
| Q2 2025 | 920 | 93M | 120 / 355 | 323 / 76 | 6M | 6M |
| Q1 2025 | 885 | 94M | 109 / 348 | 290 / 82 | 7M | 3M |
| Q4 2024 | 871 | 91M | 151 / 333 | 264 / 69 | 9M | 6M |
| Q3 2024 | 803 | 88M | 111 / 324 | 258 / 73 | 18M | 6M |
| Q2 2024 | 773 | 87M | 117 / 309 | 241 / 54 | 8M | 9M |
| Q1 2024 | 717 | 89M | 98 / 292 | 217 / 61 | 11M | 6M |
| Q4 2023 | 688 | 84M | 112 / 246 | 242 / 74 | 9M | 13M |
| Q3 2023 | 659 | 88M | 61 / 248 | 255 / 123 | 9M | 17M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of RMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 4,605,309 | – | $897.48M | 0.04% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 3,758,092 | – | $732.38M | 0.04% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 3,143,005 | – | $612.51M | 0.27% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 1,994,871 | – | $388.76M | 0.04% | Jun 30, 2026 |
| Vanguard Growth Index Fund | 1,866,016 | – | $363.65M | 0.10% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 1,864,247 | – | $355.27M | 0.04% | May 31, 2026 |
| First Trust Rising Dividend Achievers ETF | 1,396,495 | – | $272.15M | 1.11% | Jun 30, 2026 |
| Vanguard Mid-Cap Growth Index Fund | 1,111,305 | – | $216.57M | 0.62% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 1,024,772 | – | $199.71M | 0.49% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 963,450 | – | $203.27M | 0.21% | Jul 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 820,726 | – | $173.16M | 0.13% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 787,464 | – | $153.46M | 0.04% | Jun 30, 2026 |
| iShares U.S. Medical Devices ETF | 679,275 | – | $132.38M | 4.38% | Jun 30, 2026 |
| First Trust Capital Strength ETF | 675,234 | – | $131.59M | 1.72% | Jun 30, 2026 |
| iShares Russell Mid-Cap ETF | 597,936 | – | $116.53M | 0.20% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Michael J. Farrell | Chairman and CEO, Director | 468,346 | Sep 10, 2026 |
| Michael J. Rider | Global General Counsel | 9,488 | Jun 3, 2026 |
| Brett Sandercock | Chief Financial Officer | 83,495 | May 4, 2026 |
| Aaron Bloomer | Chief Financial Officer | – | May 4, 2026 |
| Justin Leong | Chief Product Officer | 29,028 | Nov 24, 2025 |
| Kaushik Ghoshal | Chief Commercial Officer, SaaS | 19,430 | Aug 5, 2025 |
| Peter C. Farrell | Director | 1,095,977 | Sep 4, 2026 |
| Witte Jan De | Director | 4,261 | Nov 26, 2025 |
| Nicole Mowad-Nassar | Director | 777 | Nov 26, 2025 |
| Karen Drexler | Director | 10,602 | Nov 24, 2025 |
| Christopher DelOrefice | Director | 2,423 | Nov 24, 2025 |
| Carol Burt | Director | 18,816 | Nov 24, 2025 |
| John Hernandez | Director | 5,118 | Nov 24, 2025 |
| Desney Tan | Director | 6,002 | Nov 24, 2025 |
| Ronald R. Taylor | Director | 24,771 | Nov 24, 2025 |
| Harjit Gill | Director | 10,940 | Nov 24, 2025 |
| Richard Sulpizio | Director | 17,796 | Nov 21, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Michael J. Farrell Chairman and CEO, Director | Sep 8, 2026 | Sale(10b5-1 plan) | −4,991 | $222.44 | $1.11M | 466,256 |
| Michael J. Farrell Chairman and CEO, Director | Sep 8, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,247 |
| Peter C. Farrell Director | Sep 2, 2026 | Sale(10b5-1 plan) | −970 | $234.73 | $227.69K | 51,803 |
| Michael J. Farrell Chairman and CEO, Director | Aug 7, 2026 | Sale(10b5-1 plan) | −4,991 | $205.69 | $1.03M | 466,256 |
| Michael J. Farrell Chairman and CEO, Director | Aug 7, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,247 |
| Peter C. Farrell Director | Aug 5, 2026 | Sale(10b5-1 plan) | −8,000 | $225.00 | $1.80M | 52,773 |
| Michael J. Farrell Chairman and CEO, Director | Jul 7, 2026 | Sale(10b5-1 plan) | −4,991 | $218.55 | $1.09M | 466,223 |
| Michael J. Farrell Chairman and CEO, Director | Jul 7, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Michael J. Farrell Chairman and CEO, Director | Jun 8, 2026 | Sale(10b5-1 plan) | −4,991 | $193.96 | $968.05K | 466,256 |
| Michael J. Farrell Chairman and CEO, Director | Jun 8, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Michael J. Rider Global General Counsel | Jun 1, 2026 | Tax withholding | −268.74 | $190.57 | $51.21K | 9,488 |
| Michael J. Farrell Chairman and CEO, Director | May 7, 2026 | Sale(10b5-1 plan) | −4,991 | $207.82 | $1.04M | 466,223 |
| Michael J. Farrell Chairman and CEO, Director | May 7, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Michael J. Farrell Chairman and CEO, Director | Apr 7, 2026 | Sale(10b5-1 plan) | −4,991 | $225.50 | $1.13M | 466,223 |
| Michael J. Farrell Chairman and CEO, Director | Apr 7, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Brett Sandercock Chief Financial Officer | Apr 1, 2026 | Sale(10b5-1 plan) | −1,000 | $224.31 | $224.31K | 83,495 |
| Peter C. Farrell Director | Apr 1, 2026 | Sale(10b5-1 plan) | −2,000 | $225.00 | $450.00K | 60,773 |
| Michael J. Farrell Chairman and CEO, Director | Mar 9, 2026 | Sale(10b5-1 plan) | −4,991 | $251.03 | $1.25M | 466,223 |
| Michael J. Farrell Chairman and CEO, Director | Mar 9, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Peter C. Farrell Director | Mar 4, 2026 | Sale(10b5-1 plan) | −2,000 | $260.22 | $520.44K | 62,773 |
| Brett Sandercock Chief Financial Officer | Mar 2, 2026 | Sale(10b5-1 plan) | −1,000 | $254.30 | $254.30K | 84,495 |
| Michael J. Farrell Chairman and CEO, Director | Feb 9, 2026 | Sale(10b5-1 plan) | −4,991 | $273.78 | $1.37M | 466,223 |
| Michael J. Farrell Chairman and CEO, Director | Feb 9, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Michael J. Rider Global General Counsel | Feb 4, 2026 | Sale(10b5-1 plan) | −50 | $260.00 | $13.00K | 9,691 |
| Peter C. Farrell Director | Feb 4, 2026 | Sale(10b5-1 plan) | −2,000 | $251.31 | $502.62K | 64,773 |
| Brett Sandercock Chief Financial Officer | Feb 2, 2026 | Sale(10b5-1 plan) | −1,000 | $257.03 | $257.03K | 85,495 |
| Peter C. Farrell Director | Jan 7, 2026 | Sale(10b5-1 plan) | −2,000 | $248.83 | $497.66K | 66,773 |
| Michael J. Farrell Chairman and CEO, Director | Jan 7, 2026 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Michael J. Farrell Chairman and CEO, Director | Jan 7, 2026 | Sale(10b5-1 plan) | −4,991 | $248.46 | $1.24M | 466,223 |
| Michael J. Rider Global General Counsel | Jan 2, 2026 | Sale(10b5-1 plan) | −50 | $241.75 | $12.09K | 9,741 |
| Brett Sandercock Chief Financial Officer | Jan 2, 2026 | Sale(10b5-1 plan) | −1,000 | $241.75 | $241.75K | 86,495 |
| Michael J. Farrell Chairman and CEO, Director | Dec 8, 2025 | Sale(10b5-1 plan) | −4,991 | $251.41 | $1.25M | 466,223 |
| Michael J. Farrell Chairman and CEO, Director | Dec 8, 2025 | Option exercise | +4,991 | $146.34 | $730.38K | 471,214 |
| Peter C. Farrell Director | Dec 3, 2025 | Sale(10b5-1 plan) | −2,000 | $251.47 | $502.94K | 68,773 |
| Michael J. Rider Global General Counsel | Dec 1, 2025 | Sale(10b5-1 plan) | −50 | $244.16 | $12.21K | 9,791 |
| Brett Sandercock Chief Financial Officer | Dec 1, 2025 | Sale(10b5-1 plan) | −1,000 | $244.16 | $244.16K | 87,495 |
| Witte Jan De Director | Nov 25, 2025 | Sale(10b5-1 plan) | −2,055 | $255.00 | $524.03K | 4,261 |
| Christopher DelOrefice Director | Nov 20, 2025 | Award | +1,073 | – | – | 2,423 |
| Ronald R. Taylor Director | Nov 20, 2025 | Award | +1,073 | – | – | 24,771 |
| Witte Jan De Director | Nov 20, 2025 | Award | +1,073 | – | – | 6,316 |
| Brett Sandercock Chief Financial Officer | Nov 20, 2025 | Award | +2,710 | – | – | 88,495 |
| Michael J. Farrell Chairman and CEO, Director | Nov 20, 2025 | Tax withholding | −7,297 | – | – | 466,223 |
| Michael J. Farrell Chairman and CEO, Director | Nov 20, 2025 | Award | +13,551 | – | – | 473,520 |
| Peter C. Farrell Director | Nov 20, 2025 | Award | +536 | – | – | 70,773 |
| Nicole Mowad-Nassar Director | Nov 20, 2025 | Award | +536 | – | – | 777 |
| John Hernandez Director | Nov 20, 2025 | Award | +1,073 | – | – | 5,118 |
| Desney Tan Director | Nov 20, 2025 | Award | +1,073 | – | – | 6,002 |
| Harjit Gill Director | Nov 20, 2025 | Award | +1,073 | – | – | 10,940 |
| Justin Leong Chief Product Officer | Nov 20, 2025 | Award | +1,848 | – | – | 29,028 |
| Carol Burt Director | Nov 20, 2025 | Award | +1,073 | – | – | 2,156 |
| Karen Drexler Director | Nov 20, 2025 | Award | +1,073 | – | – | 10,602 |
| Peter C. Farrell Director | Nov 14, 2025 | Tax withholding | −7,314 | $244.46 | $1.79M | 70,238 |
| Peter C. Farrell Director | Nov 14, 2025 | Option exercise | +11,442 | $101.64 | $1.16M | 77,552 |
| Peter C. Farrell Director | Nov 12, 2025 | Sale(10b5-1 plan) | −2,000 | $252.05 | $504.10K | 66,110 |
| Harjit Gill Director | Nov 11, 2025 | Tax withholding | −38.21 | $250.10 | $9.56K | 9,867 |
| Peter C. Farrell Director | Nov 11, 2025 | Tax withholding | −162.95 | $250.10 | $40.75K | 68,110 |
| Witte Jan De Director | Nov 11, 2025 | Sale(10b5-1 plan) | −487 | $250.25 | $121.87K | 5,319 |
| Witte Jan De Director | Nov 11, 2025 | Tax withholding | −76.45 | $250.10 | $19.12K | 5,242 |
| Michael J. Farrell Chairman and CEO, Director | Nov 11, 2025 | Tax withholding | −2,205.7 | $250.10 | $551.65K | 459,969 |
| Michael J. Farrell Chairman and CEO, Director | Nov 11, 2025 | Tax withholding | −2,231.55 | $250.10 | $558.11K | 465,634 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Michael J. Farrell Officer, Director | Oct 7, 2026 | 4,991 | $1.13M | Oct 7, 2026 | Stock Option Exercise |
| Michael J. Farrell Officer, Director | Sep 8, 2026 | 4,991 | $1.13M | Sep 8, 2026 | Stock Option Exercise |
| C. Farrell Peter Director | Sep 2, 2026 | 970 | $227.61K | Sep 2, 2026 | Stock Option |
| Michael J. Farrell Officer, Director | Aug 7, 2026 | 4,991 | $1.03M | Aug 7, 2026 | Stock Option Exercise |
| C. Farrell Peter Director | Aug 5, 2026 | 8,000 | $1.80M | Aug 5, 2026 | Stock Option |
| Michael J. Farrell Officer, Director | Jul 7, 2026 | 4,991 | $1.09M | Jul 7, 2026 | Stock Option Exercise |
| Michael J. Farrell Officer, Director | Jun 8, 2026 | 4,991 | $968.25K | Jun 8, 2026 | Stock Option Exercise |
| Brett Sandercock Former Officer | May 27, 2026 | 8,000 | $1.67M | May 27, 2026 | Restricted Stock Vesting |
| Michael J. Farrell Officer, Director | May 7, 2026 | 4,991 | $1.04M | May 7, 2026 | Option Granted - 11/21/2019 |
| Michael J. Farrell Officer, Director | Apr 7, 2026 | 4,991 | $1.13M | Apr 7, 2026 | Option Granted - 11/21/2019 |
| Brett Sandercock Officer | Apr 1, 2026 | 1,000 | $224.31K | Apr 1, 2026 | Restricted Stock Vesting |
| C. Farrell Peter Director | Apr 1, 2026 | 2,000 | $449.92K | Apr 1, 2026 | Stock Option |
| Michael J. Farrell Officer, Director | Mar 9, 2026 | 4,991 | $1.25M | Mar 9, 2026 | Options Granted 11/21/2019 |
| C. Farrell Peter Director | Mar 4, 2026 | 2,000 | $520.36K | Mar 4, 2026 | Stock Option |
| Brett Sandercock Officer | Mar 2, 2026 | 1,000 | $254.30K | Mar 2, 2026 | Restricted Stock Vesting |